Christopher Runz
@drrunz-urology.bsky.social
Urologist, interested in all things tech, minimally invasive, husband to @JenniferRunz, father, views=my own https://app.wellprept.com/christopher-runz
Reposted by Christopher Runz
90% of people diagnosed with pancreatic cancer die from the disease. That's why the medical community is excited about the results of a small trial in which nearly half of the pancreatic cancer patients who received an mRNA vaccine for the disease remained relapse-free three years later.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
www.sciencefriday.com
March 16, 2025 at 2:09 PM
90% of people diagnosed with pancreatic cancer die from the disease. That's why the medical community is excited about the results of a small trial in which nearly half of the pancreatic cancer patients who received an mRNA vaccine for the disease remained relapse-free three years later.
Reposted by Christopher Runz
Further data helping us personalise advanced prostate cancer treatment from a meta-analysis from @mrcnihrtmrp.bsky.social @ascocancer.bsky.social #GU25
February 13, 2025 at 5:30 PM
Further data helping us personalise advanced prostate cancer treatment from a meta-analysis from @mrcnihrtmrp.bsky.social @ascocancer.bsky.social #GU25
Reposted by Christopher Runz
Loving these data which are so aligned with preclinical studies showing the importance of PARP for AR activity. Fantastic to see the science move to clinical benefit! #GU25
@neerajka.bsky.social
@neerajka.bsky.social
February 13, 2025 at 4:55 PM
Loving these data which are so aligned with preclinical studies showing the importance of PARP for AR activity. Fantastic to see the science move to clinical benefit! #GU25
@neerajka.bsky.social
@neerajka.bsky.social